Yama Abassi, PhD
New Market Development, Cell & Gene Therapies, Cell Analysis Division, Agilent Technologies
Dr. Yama A. Abassi received his undergraduate degree in biochemistry with Honors from SUNY/Stony Brook in May of 1992 and a PhD degree in Molecular, Cell and Developmental Biology from University of California at Santa Barbara in 1999. Dr. Abassi joined the Burnham Institute for Cancer Research as an NIH Post-Doctoral fellow in 1999 and performed his research on understanding the molecular and genetic basis of cancer. His research was published in several peer-reviewed and internationally recognized journals. Subsequent to post-doctoral training, Dr. Abassi joined the Biopharma industry to develop targeted therapies for cancer and work on personalized medicine. Dr. Abassi has also developed unique technologies for screening of novel drugs against cancer and other diseases. He has over 10 issued patent applications and has authored over 30 research publications. Dr. Abassi is currently working on developing novel technologies and methods for in process measurement and monitoring of cell therapies quality attributes and how such solutions can be used for process development and optimization as well as for manufacturing of donor samples.